Delivery Order SPE2DB20D1100-SPE2DB24FD5J1

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,259.50 firm-fixed-price delivery order is for the supply of 4,567,828,791 units of the medication Nayzilam (5 mg nasal sprays). The contract has an ultimate completion date of April 8, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,540.06 firm fixed-price delivery order is for the supply of 4,567,925,570 units of the drug NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.34 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a $3,156.81 firm fixed-price delivery order for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to AmerisourceBergen Drug Corporation for the supply of NAYZILAM 5 MG nasal sprays. The $1,008.39 firm fixed-price contract has an ultimate completion date of August 30, 2022. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which does not have a set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, under a Firm Fixed Price contract valued at $1,149.50. The contract has an ultimate completion date of October 18, 2024 and was awarded on October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.44 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,391.00 Firm Fixed Price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has an ultimate completion date of April 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order with a ceiling value of $1,974.49 and a period of performance through February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.54 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a completion date of October 24, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD5J1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Nayzilam 5 mg nasal sprays. The $4,451.02 firm fixed-price delivery order has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This contract award is not designated as a set-aside.

Generated 11/28/24, 9:38 AM